Table 2.
Clinical infection characteristics
| Group | Total | MDR | Pyuria | Antibiotic use | LUTS | Chronic infection | Uncomplicated infection | Complicated infection | Pyelonephritis |
|---|---|---|---|---|---|---|---|---|---|
| All samples | 78 | 45 (58%) | 42 (54%) | 36 (46%) | 26 (33%) | 34 (44%) | 9 (12%) | 63 (81%) | 5 (6%) |
| BF+ | 41 | 14 (34%)* | 23 (56%) | 16 (39%) | 14 (34%) | 15 (37%) | 6 (15%) | 34 (83%) | 1 (2%) |
| BF− | 37 | 31 (84%)* | 19 (51%) | 20 (54%) | 12 (32%) | 19 (51%) | 3 (8%) | 29 (78%) | 4 (11%) |
Aggregate clinical sign data associated with all isolates, n = 78. Percentages represent proportion within groups. Abbreviations: BF+, dogs with biofilm‐forming E. coli isolates; BF−, dogs with nonbiofilm‐forming E. coli isolates; LUTS, lower urinary tract signs; MDR, multidrug resistance. * = significant difference within group with P < .01.